This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: National Health Research Institutes. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Santai Shen: Innovator in Antibody Research
Introduction
Santai Shen is a notable inventor based in Miaoli County, Taiwan. He has made significant contributions to the field of antibody research, particularly in the development of innovative solutions for health-related challenges. His work is recognized for its potential impact on therapeutic applications.
Latest Patents
Santai Shen holds a patent for "Anti-Abeta antibodies and uses thereof." This patent describes an isolated antibody that includes specific sequences for light-chain and heavy-chain complementarity-determining regions (CDRs). The antibody is designed to specifically bind to Aβ or an N-terminal modified form thereof, showcasing its relevance in addressing conditions associated with amyloid-beta.
Career Highlights
Santai Shen is affiliated with the National Health Research Institutes, where he engages in cutting-edge research. His work focuses on the intersection of immunology and therapeutic development, contributing to advancements in medical science.
Collaborations
He collaborates with esteemed colleagues, including Feng-Shiun Shie and Tsu-An Hsu, who contribute to the research environment and enhance the innovation process.
Conclusion
Santai Shen's contributions to antibody research exemplify the importance of innovation in healthcare. His patent and collaborative efforts reflect a commitment to advancing scientific knowledge and improving therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile